Targeting and hematopoietic suppression of human CD34+ cells by measles virus

被引:48
|
作者
Manchester, M
Smith, KA
Eto, DS
Perkin, HB
Torbett, BE
机构
[1] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Ctr Integrat Mol Biosci, La Jolla, CA 92037 USA
关键词
D O I
10.1128/JVI.76.13.6636-6642.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The major cause of mortality in measles is generalized suppression of cell-mediated immunity that persists following virus clearance and results in secondary infections. The mechanisms contributing to this long-term immunosuppression are not clear. Herein we present evidence that measles virus (MV) disrupts hematopoiesis by infecting human CD34(+) cells and human bone marrow stroma. MY infection does not affect the hematopoietic capability of hematopoietic stem cells (HSCs) directly; rather, the infection impairs the ability of stroma to support development of HSCs. These results suggest that MV-mediated defects in hematopoiesis contribute to the long-term immunosuppression seen in measles.
引用
收藏
页码:6636 / 6642
页数:7
相关论文
共 50 条
  • [41] Induction of apoptosis by chemotherapeutic drugs on CD34+/CD38+and CD34+/CD38-hematopoietic progenitor cells.
    Chow, KU
    Stieler, M
    Martin, H
    Rummel, MJ
    Weidmann, E
    Hoelzer, D
    Mitrou, PS
    BLOOD, 1999, 94 (10) : 154B - 154B
  • [42] FUNCTIONAL ANALYSES OF HUMAN HEMATOPOIETIC CD133+CD34+ AND CD133LOW/-CD34+ CELLS CHALLENGE THE EXISTENCE OF HUMAN COMMON MYELOID PROGENITOR CELLS
    Goergens, Andre
    Radtke, Stefan
    Moellmann, Michael
    Duerig, Jan
    Horn, Peter
    Giebel, Bernd
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S124 - S124
  • [43] Who is hematopoietic stem cell:: CD34+ or CD34-?
    Pei, XT
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 70 (04) : 213 - 215
  • [44] Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells
    Re, MC
    Monari, P
    Gibellini, D
    Ciancianaini, P
    Dall'Aglio, PP
    Vignoli, M
    Furlini, G
    Ramazzotti, E
    Bertazzoni, U
    Casoli, C
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (04): : 481 - 487
  • [45] Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells
    Hanenberg, H
    Hashino, K
    Konishi, H
    Hock, RA
    Kato, I
    Williams, DA
    HUMAN GENE THERAPY, 1997, 8 (18) : 2193 - 2206
  • [46] FACTORS AFFECTING RETROVIRAL GENE-TRANSFER INTO CD34+ HUMAN HEMATOPOIETIC PROGENITOR CELLS
    MAURER, AB
    GANSER, A
    BRAND, H
    OTTMANN, OG
    RUBSAMENWAIGMANN, H
    HOELZER, D
    GREZ, M
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 752 - 752
  • [47] Infection of CD34+ hematopoietic progenitor cells by human herpesvirus 7 (HHV-7)
    Mirandola, P
    Secchiero, P
    Pierpaoli, S
    Visani, G
    Zamai, L
    Vitale, M
    Capitani, S
    Zauli, G
    BLOOD, 2000, 96 (01) : 126 - 131
  • [48] Stable gene transfer to human CD34+ hematopoietic cells using the Sleeping Beauty transposon
    Hollis, Roger P.
    Nightingale, Sarah J.
    Wang, Xiuli
    Pepper, Karen A.
    Yu, Xiao-Jin
    Barsky, Lora
    Crooks, Gay M.
    Kohn, Donald B.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (10) : 1333 - 1343
  • [49] Human CD34+ hematopoietic stem cells culture in humanized culture medium for cell therapy
    Yaghoubi, Yoda
    Zamani, Majid
    Naimi, Adel
    Hassanzadeh, Ali
    Gharibeh, Nastaran
    Madani, Javad
    Motevali, Roza
    Nikshad, Aylin
    Aghlmandi, Afsoon
    Parhizkar, Forough
    Mehdizadeh, Amir
    Nazari, Mehdi
    Yousefi, Mehdi
    Movassaghpour, Ali Akbar
    GENE REPORTS, 2020, 20
  • [50] Hematopoietic and myeloprotective activities of an acidic Angelica sinensis polysaccharide on human CD34+ stem cells
    Lee, Ji-Gua
    Hsieh, Wen-Ting
    Chen, Shee-Uan
    Chiang, Been-Huang
    JOURNAL OF ETHNOPHARMACOLOGY, 2012, 139 (03) : 739 - 745